GSKXXXX
GSK PLC
12 superinvestors own GSKXXXX
Based on latest 13F filings — data is 45–90 days delayed
| Investor | Weight | Activity |
|---|---|---|
| Kahn Brothers Group | 6.44% | Reduced |
| Hillman Capital Management | 3.75% | Held |
| Dodge & Cox | 2.24% | Reduced |
| Kenneth Fisher | 0.60% | Added |
| Tweedy Browne Co. | 0.19% | Reduced |
| William Von Mueffling | 0.12% | Held |
| Bruce Berkowitz | 0.05% | New |
| Thomas Gayner | 0.03% | Held |
| Christopher Davis | 0.01% | Held |
| First Eagle Investment Management | 0.01% | Added |
| Bill Nygren | 0.00% | Reduced |
| Jensen Investment Management | 0.00% | Held |
Recent insider activity — GSKXXXX
Open-market purchases (P) and sales (S) from SEC Form 4 filings · last 12 months
No open-market insider trades in the last 12 months.
Form 4 filings for option exercises and other transaction types are excluded.
Congressional trades — GSKXXXX
STOCK Act disclosures · last 12 months
Congressional trade data coming soon.
We are sourcing STOCK Act disclosures and will display them here shortly.
Learn more
What Is SEC Form 4?
Understand the insider trade filings behind GSKXXXX activity.
What Is a 13F Filing?
How superinvestors disclose their quarterly holdings.
Insider Cluster Buying
Why multiple insiders buying together is a strong signal.
Superinvestor Consensus
The most widely held stocks across all tracked institutions.